Loading…
ARCL Organics (ARCL)₹214.34+1.63%Commodity Chemicals
In the Jun 2026 quarter (consolidated), ARCL Organics reported sales of ₹66.88 Cr, down 0.6% from Jun 2025, and net profit of ₹9.11 Cr, up 128.9% year on year. For the year to Mar 2026, sales were ₹272 Cr and net profit ₹4.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.20 | 48.31 | 57.56 | 59.89 | 56.44 | 61.93 | 72.18 | 67.27 | 86.12 | 53.46 | 65.22 | 66.88 |
| Expenses | 39.38 | 41.07 | 52.10 | 53.89 | 51.03 | 57.94 | 63.02 | 60.61 | 74.46 | 53.57 | 57.96 | 51.14 |
| Operating Profit | 3.73 | 7.12 | 5.29 | 5.80 | 5.26 | 3.83 | 8.94 | 6.46 | 11.41 | −0.31 | 7.08 | 15.62 |
| OPM % | 8.7% | 14.8% | 9.2% | 9.7% | 9.3% | 6.2% | 12.4% | 9.6% | 13.3% | −0.6% | 10.9% | 23.4% |
| Other Income | 0.65 | 0.82 | 0.83 | 0.42 | 0.72 | 0.84 | 0.41 | 0.84 | 1.19 | 0.60 | 0.79 | 0.94 |
| Interest | 0.68 | 1.38 | 0.47 | 1.07 | 1.07 | 0.97 | 1.06 | 0.98 | 0.83 | 1.37 | 1.74 | 1.74 |
| Depreciation | 1.30 | 1.18 | 0.51 | 1.38 | 1.14 | 1.30 | 1.43 | 1.40 | 1.50 | 1.52 | 1.64 | 1.91 |
| Profit before tax | 2.39 | 5.37 | 5.13 | 3.74 | 3.78 | 2.39 | 6.85 | 4.93 | 10.28 | −2.63 | 4.50 | 12.92 |
| Tax % | 47.9% | 29.4% | 1.9% | 26.1% | 42.4% | 24.4% | 18.5% | 18.7% | 29.7% | 236.3% | 37.9% | 29.3% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 |
| Net Profit | 1.24 | 3.79 | 5.03 | 2.76 | 2.17 | 1.78 | 5.59 | 3.98 | 7.21 | −8.80 | 2.78 | 9.11 |
| EPS (Rs) | 1.55 | 4.73 | 6.28 | 3.45 | 2.71 | 2.23 | 6.97 | 4.98 | 8.99 | −10.96 | 3.48 | 11.36 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 70.97 | 70.97 | 86.99 | 141 | 165 | 191 | 251 | 272 | 272 |
| Expenses | 66.72 | 63.72 | 73.74 | 126 | 146 | 170 | 226 | 247 | 237 |
| Operating Profit | 3.99 | 6.99 | 11.99 | 14.98 | 17.99 | 18.99 | 23.99 | 24.97 | 33.80 |
| OPM % | 6.0% | 9.0% | 14.0% | 11.0% | 11.0% | 10.0% | 10.0% | 9.0% | 12.4% |
| Other Income | 1.01 | 1.01 | 2.01 | 2.01 | 3.01 | 3.01 | 2.01 | 3.01 | 3.52 |
| Interest | 1.99 | 2.99 | 1.99 | 0.99 | 1.99 | 2.99 | 3.99 | 4.99 | 5.68 |
| Depreciation | 1.01 | 1.01 | 1.01 | 1.01 | 3.01 | 4.01 | 5.01 | 6.01 | 6.57 |
| Profit before tax | 1.01 | 2.99 | 11.01 | 15.01 | 16.98 | 14.99 | 16.99 | 17.01 | 25.07 |
| Tax % | 26.0% | 24.0% | 28.0% | 28.9% | 30.0% | 23.0% | 26.0% | 70.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 |
| Net Profit | 0.99 | 2.99 | 7.99 | 10.98 | 11.99 | 10.99 | 11.98 | 4.99 | 10.30 |
| EPS (Rs) | 1.38 | 3.14 | 10.02 | 13.11 | 14.54 | 14.07 | 15.34 | 6.47 | 12.87 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.99 | 7.99 | 7.99 | 8.01 | 8.01 | 7.99 | 7.99 | 8.01 |
| Reserves | 14.02 | 16.02 | 24.04 | 35.05 | 46.03 | 58.04 | 69.06 | 74.10 |
| Borrowings | 19.98 | 16.99 | 8.99 | 14.99 | 19.98 | 28.99 | 33.99 | 70.97 |
| Other Liabilities | 15.02 | 12.96 | 26.98 | 40.95 | 45.95 | 62.96 | 56.87 | 66.71 |
| Total Liabilities | 57.01 | 54.96 | 68.00 | 98.00 | 120 | 157 | 169 | 220 |
| Fixed Assets | 21.93 | 20.92 | 19.92 | 26.89 | 45.83 | 62.76 | 67.76 | 96.67 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 35.08 | 34.04 | 48.08 | 71.11 | 74.14 | 94.22 | 101 | 123 |
| Inventories | 5.07 | 5.72 | 6.26 | 12.19 | 12.54 | 22.11 | 14.19 | 24.25 |
| Trade receivables | 16.83 | 16.89 | 22.88 | 31.59 | 32.00 | 34.29 | 51.62 | 41.46 |
| Cash & equivalents | 7.16 | 7.30 | 8.77 | 9.08 | 16.03 | 15.09 | 18.13 | 22.70 |
| Total Assets | 57.01 | 54.96 | 68.00 | 98.00 | 120 | 157 | 169 | 220 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −1.99 | 5.99 | 5.99 | 1.99 | 24.97 | 12.98 | 4.99 | −3.99 |
| Cash from investing activity | −4.01 | 0.00 | −1.01 | −7.01 | −22.04 | −21.05 | −9.02 | −34.08 |
| Cash from financing activity | 6.98 | −4.99 | −3.99 | 4.98 | 3.99 | 6.98 | 1.99 | 31.92 |
| Net cash flow | 0.00 | 0.00 | 1.01 | −1.01 | 7.03 | −1.01 | −2.01 | −5.02 |
| Capex | 4.82 | 0.82 | 1.12 | 7.93 | 22.22 | 21.09 | 10.04 | 35.36 |
| Free cash flow | −6.98 | 4.99 | 4.98 | −5.98 | 2.99 | −7.97 | −4.98 | −38.87 |
| CFO / OP % | −55.1% | 89.9% | 59.9% | 25.9% | 151.9% | 66.0% | 21.9% | −7.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 88 | 88 | 97 | 83 | 72 | 67 | 76 | 57 |
| Inventory days | 36 | 46 | 41 | 44 | 39 | 59 | 29 | 46 |
| Days payable | 50 | 42 | 88 | 87 | 104 | 129 | 89 | 78 |
| Cash conversion cycle | 70 | 88 | 47 | 36 | 3 | −7 | 13 | 21 |
| Working capital days | 2 | 32 | 48 | 41 | 16 | 19 | 21 | 2 |
| ROCE % | — | 15.0% | 32.0% | 33.0% | 28.0% | 21.0% | 20.0% | 16.9% |
For the Jun 2026 quarter, ARCL Organics reported sales of ₹66.88 Cr, down 0.6% year on year and net profit of ₹9.11 Cr, up 128.9% year on year. The operating margin was 23.4%.
ARCL Organics' sales for the year to Mar 2026 were ₹272 Cr; over the last twelve months they were ₹272 Cr.
Net profit for the year to Mar 2026 was ₹4.99 Cr, and ₹10.30 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.87.
ARCL Organics reported borrowings of ₹70.97 Cr at Mar 2026, against cash and equivalents of ₹22.70 Cr.
Cash from operations was −₹3.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹38.87 Cr.